Vaidehi Prasanth: The Role of Viscoelastic Testing in Low- and Middle-Income Countries
Vaidehi Prasanth, Senior Resident at All India Institute of Medical Sciences, shared a post on LinkedIn about a recent article by her published in Tranfusion Medicine, adding;
”Trauma-induced coagulopathy remains a major challenge in the management of severe bleeding.
While viscoelastic testing (TEG/ROTEM) has demonstrated significant potential for guiding targeted haemostatic resuscitation, its implementation in low- and middle-income countries is often limited by financial, infrastructural, logistical, and training-related barriers.
In this article, the main focus is about:
- Current evidence comparing viscoelastic testing with conventional coagulation tests in trauma care.
- Challenges affecting adoption of VET-guided algorithms in resource limited settings.
- Practical and evidence based strategies to strengthen trauma haemorrhage management.
- The importance of patient blood management and system-level improvements in LMICs.
I am grateful to my mentors, faculty, and colleagues whose discussions and insights contributed to this work.”
Title: Viscoelastic testing versus conventional coagulation tests in trauma-induced coagulopathy: Barriers to implementation in low- and middle-income countries
Authers: Vaidehi Prasanth

Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian